Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Fcrla (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of FCRLA mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | Fcrla (Mus musculus) | 6480464 | Estradiol results in decreased expression of FCRLA mRNA | CTD | PMID:19484750 | 17beta-estradiol | multiple interactions | ISO | FCRLA (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of FCRLA mRNA | CTD | PMID:30165855 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FCRLA mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FCRLA mRNA | CTD | PMID:33387578 | 2-methoxyethanol | decreases expression | EXP | | 6480464 | methyl cellosolve results in decreased expression of FCRLA mRNA | CTD | PMID:21061450 | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of FCRLA mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of FCRLA mRNA | CTD | PMID:21641981 | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of FCRLA mRNA | CTD | PMID:35163327 | benzene | decreases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Benzene results in decreased expression of FCRLA mRNA | CTD | PMID:19162166 | benzo[a]pyrene | decreases expression | ISO | Fcrla (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FCRLA mRNA | CTD | PMID:21569818 | benzo[a]pyrene | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of FCRLA mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | FCRLA (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of FCRLA promoter | CTD | PMID:27901495 | benzo[b]fluoranthene | increases expression | ISO | Fcrla (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of FCRLA mRNA | CTD | PMID:26377693 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FCRLA mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases expression | ISO | Fcrla (Mus musculus) | 6480464 | bisphenol A results in increased expression of FCRLA mRNA | CTD | PMID:32156529 | bisphenol A | decreases methylation | ISO | FCRLA (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of FCRLA gene | CTD | PMID:31601247 | buta-1,3-diene | decreases expression | ISO | Fcrla (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of FCRLA mRNA | CTD | PMID:29038090 | cadmium atom | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Cadmium results in increased expression of FCRLA mRNA | CTD | PMID:21120746 | cadmium atom | multiple interactions | ISO | FCRLA (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FCRLA mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | FCRLA (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FCRLA mRNA | CTD | PMID:35301059 | capecitabine | decreases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Capecitabine results in decreased expression of FCRLA mRNA | CTD | PMID:36183961 | carbon nanotube | decreases expression | ISO | Fcrla (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25926378 | CGP 52608 | multiple interactions | ISO | FCRLA (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to FCRLA gene] | CTD | PMID:28238834 | chloroprene | decreases expression | ISO | Fcrla (Mus musculus) | 6480464 | Chloroprene results in decreased expression of FCRLA mRNA | CTD | PMID:23125180 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of FCRLA mRNA | CTD | PMID:27523638 | dexamethasone phosphate | multiple interactions | EXP | | 6480464 | dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of FCRLA mRNA] | CTD | PMID:36996615 | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of FCRLA mRNA | CTD | PMID:36653537 | dimethylarsinic acid | multiple interactions | ISO | Fcrla (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCRLA mRNA | CTD | PMID:34876320 | dioxygen | multiple interactions | ISO | Fcrla (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCRLA mRNA | CTD | PMID:30529165 | doxorubicin | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of FCRLA mRNA | CTD | PMID:30031762 | doxorubicin | decreases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of FCRLA mRNA | CTD | PMID:29803840 | ethanol | decreases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Ethanol results in decreased expression of FCRLA mRNA | CTD | PMID:31059573 | ethyl methanesulfonate | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of FCRLA mRNA | CTD | PMID:23649840 | formaldehyde | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of FCRLA mRNA | CTD | PMID:23649840 | formaldehyde | affects response to substance | ISO | FCRLA (Homo sapiens) | 6480464 | FCRLA gene affects the susceptibility to Formaldehyde | CTD | PMID:27008852 | fragrance | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Perfume results in increased expression of FCRLA mRNA | CTD | PMID:24768652 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of FCRLA mRNA | CTD | PMID:27387713 | genistein | increases expression | ISO | Fcrla (Mus musculus) | 6480464 | Genistein results in increased expression of FCRLA mRNA | CTD | PMID:22553218 | glyphosate | decreases methylation | EXP | | 6480464 | Glyphosate results in decreased methylation of FCRLA gene | CTD | PMID:31011160 | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of FCRLA mRNA | CTD | PMID:36996615 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of FCRLA mRNA] | CTD | PMID:36996615 | mercury atom | decreases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Mercury results in decreased expression of FCRLA mRNA | CTD | PMID:16823088 | mercury(0) | decreases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Mercury results in decreased expression of FCRLA mRNA | CTD | PMID:16823088 | methylarsonic acid | multiple interactions | ISO | Fcrla (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCRLA mRNA | CTD | PMID:34876320 | methylisothiazolinone | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of FCRLA mRNA | CTD | PMID:31629900 | nickel atom | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Nickel results in increased expression of FCRLA mRNA | CTD | PMID:25583101 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of FCRLA mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FCRLA mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Fcrla (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FCRLA mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FCRLA mRNA | CTD | PMID:34911549 | PCB138 | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | sodium arsenate | multiple interactions | ISO | Fcrla (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCRLA mRNA | CTD | PMID:34876320 | sodium arsenite | decreases expression | ISO | FCRLA (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of FCRLA mRNA | CTD | PMID:29301061 | sodium arsenite | multiple interactions | ISO | Fcrla (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCRLA mRNA | CTD | PMID:34876320 | sodium arsenite | increases expression | ISO | Fcrla (Mus musculus) | 6480464 | sodium arsenite results in increased expression of FCRLA mRNA | CTD | PMID:37682722 | temozolomide | decreases expression | ISO | FCRLA (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of FCRLA mRNA | CTD | PMID:31758290 | tetraphene | increases expression | ISO | Fcrla (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of FCRLA mRNA | CTD | PMID:26377693 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of FCRLA mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Fcrla (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of FCRLA mRNA | CTD | PMID:23409001 | titanium dioxide | increases expression | ISO | Fcrla (Mus musculus) | 6480464 | titanium dioxide results in increased expression of FCRLA mRNA | CTD | PMID:23557971 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FCRLA mRNA | CTD | PMID:25729387 | triptonide | increases expression | ISO | Fcrla (Mus musculus) | 6480464 | triptonide results in increased expression of FCRLA mRNA | CTD | PMID:33045310 | triticonazole | decreases expression | EXP | | 6480464 | triticonazole results in decreased expression of FCRLA mRNA | CTD | PMID:36084822 | valproic acid | affects expression | ISO | Fcrla (Mus musculus) | 6480464 | Valproic Acid affects the expression of FCRLA mRNA | CTD | PMID:17963808 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FCRLA mRNA | CTD | PMID:35594946 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of FCRLA mRNA | CTD | PMID:20566332 | zoledronic acid | increases expression | ISO | FCRLA (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of FCRLA mRNA | CTD | PMID:24714768 | |